NCT03543475

Brief Summary

Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Different strategies have been studied for prevention of spontaneous PTB (SPTB) in randomized controlled trials (RCTs), including progesterone, cerclage, cervical pessary, as well as lifestyle modification, such as smoking cessation, diet, aerobic exercise, and nutritional supplements. Most successful effort to reduce the incidence of SPTB have focused on asympatomatic women with risk factors, such as prior SPTB or short cervix. However, most SPTB occur in symptomatic women, i.e. women with preterm labor (PTL). Women with arrested PTL are at increased risk of SPTB. The cervical pessary is a silicone device that has been used to prevent SPTB. The leading hypotheses for its mechanisms are two: that the pessary helps to keep the cervix closed, and that the pessary changes the inclination of the cervical canal so that the pregnancy weight is not directly above the internal os. The aim of the study is to assess the efficacy of pessary in reducing preterm birth in women with arrested preterm labor

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 1, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

December 19, 2019

Status Verified

December 1, 2019

Enrollment Period

1.3 years

First QC Date

April 30, 2018

Last Update Submit

December 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pre-term Birth

    delivery before 37 weeks of gestations

    at the time of delivery

Secondary Outcomes (6)

  • Pre-term Birth <34, <32, and <28 weeks

    at the time of delivery

  • Mean gestational age at delivery in weeks

    at the time of delivery

  • Mean latency in days

    at the time of delivery

  • Maternal side effects related to the intervention

    at the time of delivery

  • Chorioamnionitis

    at the time of delivery

  • +1 more secondary outcomes

Study Arms (2)

Pessary

EXPERIMENTAL

Silicon device applied on the cervix

Device: arabin pessary

No Pessary

ACTIVE COMPARATOR

standard care, no pessary

Device: no pessary

Interventions

arabin pessary: silicon device

Pessary

control group

No Pessary

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsonly pregnant women
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Singleton gestations
  • Diagnosis of arrested PTL
  • years of age
  • TVU CL ≤25mm at the time of randomization

You may not qualify if:

  • Multiple gestations
  • Rupture of membranes at the time of randomization
  • Known major fetal structural (i.e. defined as those that are lethal or require prenatal or postnatal surgery) or chromosomal abnormality
  • Fetal death at the time of randomization
  • Cerclage in situ at the time of randomization
  • Pessary in situ at the time of randomization
  • Vaginal bleeding at the time of randomization
  • Women who are unconscious, severly ill, mentally handicapped, or under the age of 18 years
  • Placenta previa and/or accreta
  • Ballooning of membranes outside the cervix into the vaginal or TVU CL = 0mm at the time of randomization
  • Painful and regular uterine contractions at the time of randomization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Naples Federico II

Naples, 80100, Italy

Location

Related Publications (1)

  • Mastantuoni E, Saccone G, Gragnano E, Di Spiezio Sardo A, Zullo F, Locci M; Italian Preterm Birth Prevention Working Group. Cervical pessary in singleton gestations with arrested preterm labor: a randomized clinical trial. Am J Obstet Gynecol MFM. 2021 Mar;3(2):100307. doi: 10.1016/j.ajogmf.2021.100307. Epub 2021 Jan 7.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 30, 2018

First Posted

June 1, 2018

Study Start

June 1, 2018

Primary Completion

September 4, 2019

Study Completion

November 1, 2019

Last Updated

December 19, 2019

Record last verified: 2019-12

Locations